284 related articles for article (PubMed ID: 34390968)
1. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment.
Lv Y; Fan M; He J; Song X; Guo J; Gao B; Zhang J; Zhang C; Xie Y
Eur J Med Chem; 2024 Aug; 274():116566. PubMed ID: 38838545
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T
Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
[TBL] [Abstract][Full Text] [Related]
6. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L
Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056
[TBL] [Abstract][Full Text] [Related]
7. Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation.
Kong H; Meng X; Hou R; Yang X; Han J; Xie Z; Duan Y; Liao C
Bioorg Med Chem Lett; 2021 Jul; 43():128051. PubMed ID: 33887441
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
[TBL] [Abstract][Full Text] [Related]
9. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
Leonetti F; Capaldi C; Pisani L; Nicolotti O; Muncipinto G; Stefanachi A; Cellamare S; Caccia C; Carotti A
J Med Chem; 2007 Oct; 50(20):4909-16. PubMed ID: 17824599
[TBL] [Abstract][Full Text] [Related]
11. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
12. Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
Chavarria D; Fernandes C; Silva V; Silva C; Gil-Martins E; Soares P; Silva T; Silva R; Remião F; Oliveira PJ; Borges F
Eur J Med Chem; 2020 Jan; 185():111770. PubMed ID: 31711793
[TBL] [Abstract][Full Text] [Related]
13. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
Bekircan O; Danış Ö; Şahin ME; Çetin M
Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
[TBL] [Abstract][Full Text] [Related]
15. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ
Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672
[TBL] [Abstract][Full Text] [Related]
16. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation.
Seong SH; Ali MY; Jung HA; Choi JS
Bioorg Chem; 2019 Nov; 92():103293. PubMed ID: 31557622
[TBL] [Abstract][Full Text] [Related]
17. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
19. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline.
Xiao X; Zhang XX; Zhan MM; Cheng K; Li S; Xie Z; Liao C
Eur J Med Chem; 2018 Feb; 145():588-593. PubMed ID: 29339253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
